CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Lamotrigine

拉莫三嗪 杂质对照品Lamotrigine Impurities

EP36 个杂质条目36 impurity entries

本页汇总 拉莫三嗪 的 36 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 36 impurity reference standards of Lamotrigine with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 拉莫三嗪(Lamotrigine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesQuantitative determination of related substances for Lamotrigine extended release tablet by RP-HPLC
    Heliyon · 2023 · Gondhale-Karpe P, Manwatkar S  ·  PMID 37215899  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and validation of spectrophotometric, TLC and HPLC methods for the determination of lamotrigine in presence of its impurity
    Chemical & pharmaceutical bulletin · 2007 · Youssef NF, Taha EA  ·  PMID 17409544  ·  DOI
  3. 杂质研究Impurity studiesChemometric evaluation of the column classification system during the pharmaceutical analysis of lamotrigine and its related substances
    Analytical and bioanalytical chemistry · 2013 · Szulfer J et al.  ·  PMID 23812853  ·  DOI
  4. 杂质研究Impurity studies"In-source" fragmentation of an isobaric impurity of lamotrigine for its measurement by liquid chromatography tandem mass spectrometry after pre-concentration using solid phase extraction
    Journal of pharmaceutical and biomedical analysis · 2008 · Carrier DJ et al.  ·  PMID 18455345  ·  DOI
  5. 杂质研究Impurity studiesDevelopment and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations
    Journal of pharmaceutical and biomedical analysis · 2006 · Emami J et al.  ·  PMID 16176866  ·  DOI

拉莫三嗪 —— 原料药与杂质对照品Lamotrigine — drug substance & impurities

共 37 个条目(含原料药本体)37 items incl. the drug substance
Lamotrigine structure
EP原料药 APIAPI
拉莫三嗪Lamotrigine
Lamotrigine
CAS No.84057-84-1
Chemical FormulaC9H7Cl2N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 1 (Lamotrigine EP Impurity A) structure
EPA
拉莫三嗪杂质1 (拉莫三嗪EP杂质A)Lamotrigine Impurity 1 (Lamotrigine EP Impurity A)
Lamotrigine Impurity 1 (Lamotrigine EP Impurity A)
CAS No.252186-78-0
Chemical FormulaC9H6Cl2N4O
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 16 (Lamotrigine EP Impurity B) structure
EPB
拉莫三嗪杂质16 (拉莫三嗪EP杂质B)Lamotrigine Impurity 16 (Lamotrigine EP Impurity B)
Lamotrigine Impurity 16 (Lamotrigine EP Impurity B)
CAS No.94213-24-8
Chemical FormulaC9H7Cl2N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 2 (Lamotrigine EP Impurity C) structure
EPC
拉莫三嗪杂质2 (拉莫三嗪EP杂质C)Lamotrigine Impurity 2 (Lamotrigine EP Impurity C)
Lamotrigine Impurity 2 (Lamotrigine EP Impurity C)
CAS No.94213-23-7
Chemical FormulaC9H7Cl2N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 3 (Lamotrigine EP Impurity D) structure
EPD
拉莫三嗪杂质3 (拉莫三嗪EP杂质D)Lamotrigine Impurity 3 (Lamotrigine EP Impurity D)
Lamotrigine Impurity 3 (Lamotrigine EP Impurity D)
CAS No.661463-79-2
Chemical FormulaC9H5Cl2N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 4 (Lamotrigine EP Impurity E) structure
EPE
拉莫三嗪杂质4 (拉莫三嗪EP杂质E)Lamotrigine Impurity 4 (Lamotrigine EP Impurity E)
Lamotrigine Impurity 4 (Lamotrigine EP Impurity E)
CAS No.50-45-3
Chemical FormulaC7H4Cl2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 5 (Lamotrigine EP Impurity F) structure
EPF
拉莫三嗪杂质5 (拉莫三嗪EP杂质F)Lamotrigine Impurity 5 (Lamotrigine EP Impurity F)
Lamotrigine Impurity 5 (Lamotrigine EP Impurity F)
CAS No.252186-79-1
Chemical FormulaC16H9Cl4N5O
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 6 (Lamotrigine EP Impurity G) structure
EPG
拉莫三嗪杂质6 (拉莫三嗪EP杂质G)Lamotrigine Impurity 6 (Lamotrigine EP Impurity G)
Lamotrigine Impurity 6 (Lamotrigine EP Impurity G)
CAS No.38943-76-9
Chemical FormulaC9H7Cl2N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 8 structure
8
拉莫三嗪杂质8Lamotrigine Impurity 8
Lamotrigine Impurity 8
CAS No.35022-43-6
Chemical FormulaC8H3Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 9 structure
9
拉莫三嗪杂质9Lamotrigine Impurity 9
Lamotrigine Impurity 9
CAS No.94266-27-0
Chemical FormulaC9H7Cl2N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 10 structure
10
拉莫三嗪杂质10Lamotrigine Impurity 10
Lamotrigine Impurity 10
CAS No.77668-42-9
Chemical FormulaC8H3Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 11 structure
11
拉莫三嗪杂质11Lamotrigine Impurity 11
Lamotrigine Impurity 11
CAS No.31273-66-2
Chemical FormulaC9H8Cl2O2
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 15 structure
15
拉莫三嗪杂质15Lamotrigine Impurity 15
Lamotrigine Impurity 15
CAS No.136565-76-9
Chemical FormulaC9H7Cl2N5O
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 17 structure
17
拉莫三嗪杂质17Lamotrigine Impurity 17
Lamotrigine Impurity 17
CAS No.1797983-48-2
Chemical FormulaC19H14Cl4N10
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 20 structure
20
拉莫三嗪杂质20Lamotrigine Impurity 20
Lamotrigine Impurity 20
CAS No.1927-94-2
Chemical FormulaC7H5ClO2
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 21 structure
21
拉莫三嗪杂质21Lamotrigine Impurity 21
Lamotrigine Impurity 21
CAS No.84689-20-3
Chemical FormulaC9H7Cl2N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 22 structure
22
拉莫三嗪杂质22Lamotrigine Impurity 22
Lamotrigine Impurity 22
CAS No.252186-80-4
Chemical FormulaC14H6Cl4O3
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 23 structure
23
拉莫三嗪杂质23Lamotrigine Impurity 23
Lamotrigine Impurity 23
CAS No.51417-52-8
Chemical FormulaC14H6Cl4O3
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 24 structure
24
拉莫三嗪杂质24Lamotrigine Impurity 24
Lamotrigine Impurity 24
CAS No.64985-85-9
Chemical FormulaC8H3Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 25 structure
25
拉莫三嗪杂质25Lamotrigine Impurity 25
Lamotrigine Impurity 25
CAS No.35022-44-7
Chemical FormulaC8H3Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 26 structure
26
拉莫三嗪杂质26Lamotrigine Impurity 26
Lamotrigine Impurity 26
CAS No.94213-25-9
Chemical FormulaC9H7Cl2N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 27 structure
27
拉莫三嗪杂质27Lamotrigine Impurity 27
Lamotrigine Impurity 27
CAS No.356757-50-1
Chemical FormulaC9H7Cl2N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 28 structure
28
拉莫三嗪杂质28Lamotrigine Impurity 28
Lamotrigine Impurity 28
CAS No.2514942-90-4
Chemical FormulaC9H7BrClN5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 29 structure
29
拉莫三嗪杂质29Lamotrigine Impurity 29
Lamotrigine Impurity 29
CAS No.2518309-57-2
Chemical FormulaC9H7BrClN5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 30 structure
30
拉莫三嗪杂质30Lamotrigine Impurity 30
Lamotrigine Impurity 30
CAS No.887354-37-2
Chemical FormulaC8H8Cl2N4O
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 32 structure
32
拉莫三嗪杂质32Lamotrigine Impurity 32
Lamotrigine Impurity 32
CAS No.2090976-87-5
Chemical FormulaC8H3BrClNO
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 33 structure
33
拉莫三嗪杂质33Lamotrigine Impurity 33
Lamotrigine Impurity 33
CAS No.2250242-15-8
Chemical FormulaC16H9Cl4N5O
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 34 structure
34
拉莫三嗪杂质34Lamotrigine Impurity 34
Lamotrigine Impurity 34
CAS No.1373393-59-9
Chemical FormulaC23H11Cl6N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 35 structure
35
拉莫三嗪杂质35Lamotrigine Impurity 35
Lamotrigine Impurity 35
CAS No.180868-97-7
Chemical FormulaC8H5Cl2NO2
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 36 structure
36
拉莫三嗪杂质36Lamotrigine Impurity 36
Lamotrigine Impurity 36
CAS No.1426543-66-9
Chemical FormulaC9H7Cl2N5O
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 37 structure
37
拉莫三嗪杂质37Lamotrigine Impurity 37
Lamotrigine Impurity 37
CAS No.30885-95-1
Chemical FormulaC4H5N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 38 structure
38
拉莫三嗪杂质38Lamotrigine Impurity 38
Lamotrigine Impurity 38
CAS No.88562-25-8
Chemical FormulaC8H3Cl2NO
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 40 structure
40
拉莫三嗪杂质40Lamotrigine Impurity 40
Lamotrigine Impurity 40
CAS No.2905-60-4
Chemical FormulaC7H3Cl3O
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 42 structure
42
拉莫三嗪杂质42Lamotrigine Impurity 42
Lamotrigine Impurity 42
CAS No.942-72-3
Chemical FormulaC9H8N4
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 43 structure
43
拉莫三嗪杂质43Lamotrigine Impurity 43
Lamotrigine Impurity 43
CAS No.133310-19-7
Chemical FormulaC15H16Cl2N5O6+
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 45 structure
45
拉莫三嗪杂质45Lamotrigine Impurity 45
Lamotrigine Impurity 45
CAS No.77668-56-5
Chemical FormulaC9H6Cl3N5
Purity>95%询价On request
10mg25mg50mg100mg
Lamotrigine Impurity 46 structure
46
拉莫三嗪杂质46Lamotrigine Impurity 46
Lamotrigine Impurity 46
CAS No.6662-28-8
Chemical FormulaC9H8ClN5
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

拉莫三嗪 —— 研究文献与合成路线Lamotrigine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 拉莫三嗪 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Lamotrigine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. "In-source" fragmentation of an isobaric impurity of lamotrigine for its measurement by liquid chromatography tandem mass spectrometry after pre-concentration using solid phase extraction
    Carrier DJ, Eckers C, Wolff JC · Journal of pharmaceutical and biomedical analysis · 2008 · 被引 12cited 12
  2. Development and validation of spectrophotometric, TLC and HPLC methods for the determination of lamotrigine in presence of its impurity
    Youssef NF, Taha EA · Chemical & pharmaceutical bulletin · 2007 · 被引 8cited 8
  3. Unveiling the degradation of lamotrigine in sulfate radical-mediated oxidation: kinetics, influencing factors and transformation mechanisms
    Dong J, Wu J, Zhang J, et al. · RSC advances · 2026
  4. Detection of the principal synthetic route indicative impurity in lamotrigine
    Ashton DS, Ray AD, Valko K · International journal of pharmaceutics · 1999 · 被引 4cited 4
  5. Quantitative determination of related substances for Lamotrigine extended release tablet by RP-HPLC
    Gondhale-Karpe P, Manwatkar S · Heliyon · 2023 · 被引 2cited 2
  6. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations
    Emami J, Ghassami N, Ahmadi F · Journal of pharmaceutical and biomedical analysis · 2006 · 被引 19cited 19

合成与制备工艺专利Synthesis & process patents

  1. AN IMPROVED PROCESS FOR THE PREPARATION OF LAMOTRIGINE
    DEO KESHAV, DESAI SANJAY, SAHU RAJESH, SHARMA PRADIPKUMAR · 公开号 WO2009069073WO2009069073 · 2009
  2. A PROCESS FOR THE PREPARATION OF LAMOTRIGINE
    RODUIT JEAN-PAUL, DJOJO FRANCIS · 公开号 CA2659290CA2659290 · 2008
  3. A process for the preparation of lamotrigine
    FRANCIS DJOJO · 公开号 CN101506178CN101506178 · 2009
  4. PROCESS FOR THE PREPARATION OF LAMOTRIGINE
    RODUIT JEAN-PAUL, DJOJO FRANCIS · 公开号 US2010087638US2010087638 · 2010
  5. A PROCESS FOR THE PREPARATION OF LAMOTRIGINE
    RODUIT JEAN-PAUL, DJOJO FRANCIS · 公开号 EP2054396EP2054396 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

拉莫三嗪 杂质谱研究要点Lamotrigine — impurity profiling notes

下面这些是拿到 拉莫三嗪 的 37 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 37 impurity entries for Lamotrigine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances